The Hand-Foot Syndrome market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome: An Overview
Palmar-plantar erythrodysesthesia (PPE), also called a hand-foot syndrome, is a relatively common dermatologic toxic reaction associated with cytotoxic chemotherapy that can limit the use of such drugs.
Painful red swelling of the feet and hands in a patient receiving chemotherapy suggests the diagnosis. A high degree of suspicion is the key to diagnosis in patients receiving chemotherapeutic agents. The problem may also occur in patients with bone marrow transplants, as the clinical and histologic features may mimic cutaneous infestations of graft-versus-host disease.
Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market Key Facts
-
According to DelveInsight’s findings, males are affected more as compared to females, in the case of Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome.
-
According to V. Nikolaou et al., the incidence of PLD-associated HFS is up to 50% for any grade reactions and approximately 20% for patients with grade 3. HFS is rare with bolus 5-FU infusion, whereas it is much more common with continuous infusion (34% vs. 13%).
-
As per a study conducted by Paulo M. Hoff et al., Twenty-eight (68.3%) of the 41 patients had at least one episode of HFS. Most patients had their first (92.9%) or most severe (67.9%) episode of HFS within the first two cycles of treatment.
Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market
Hand-Foot Syndrome Market is expected to grow in the coming years owing to the increasing prevalent population and the expected launch of emerging drugs.
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Hand-Foot Syndrome market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives complete detail of the Hand-Foot Syndrome market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.
Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.
Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Epidemiology Segmentation
-
Diagnosed Cases of Hand-Foot Syndrome
-
Total Incident Cases of Hand-Foot Syndrome
-
Treatable Cases of Hand-Foot Syndrome
-
Grade-specific Incident Cases of Hand-Foot Syndrome
Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Hand-Foot Syndrome market or expected to get launched during the study period. The analysis covers Hand-Foot Syndrome market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Hand-Foot Syndrome Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Request for Sample PDF Report – https://www.delveinsight.com/sample-request/hand-foot-syndrome-market
Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Therapeutics Analysis
The Hand-Foot Syndrome market dynamics is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the complication, incremental healthcare spending across the world, and the expected launch of emerging therapies.
Some of the key companies in the Hand-Foot Syndrome Market include:
-
Processa Pharmaceuticals
-
OnQuality Pharmaceuticals
And many others
Hand-Foot Syndrome Therapies covered in the report include:
-
PCS6422
-
OQL033
And many more
Get More Detailed Insights Into the Emerging Therapies & Key Companies – https://www.delveinsight.com/sample-request/hand-foot-syndrome-market
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Competitive Intelligence Analysis
4. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market Overview at a Glance
5. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Disease Background and Overview
6. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Patient Journey
7. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Epidemiology and Patient Population
8. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Treatment Algorithm, Current Treatment, and Medical Practices
9. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Unmet Needs
10. Key Endpoints of Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Treatment
11. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Marketed Products
12. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Emerging Therapies
13. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Seven Major Market Analysis
14. Attribute Analysis
15. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market Outlook (7 major markets)
16. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Access and Reimbursement Overview
17. KOL Views on the Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market.
18. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market Drivers
19. Hand-Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF Report – https://www.delveinsight.com/sample-request/hand-foot-syndrome-market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Other Trending Healthcare Reports by DelveInsight
Spinal Decompression/Traction Devices Market
“Spinal Decompression/Traction Devices Market” research report provides comprehensive insights into the Spinal Decompression/Traction Devices market size, share, trends as well as the key companies and emerging products in the market.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/